Neoplasm
Not recruitingStudy on ANV600 and Pembrolizumab for Patients with Advanced Solid Tumors
- Disease:Neoplasm
- Substances:Anv600Pembrolizumab
France- Participants:18–64 years · 65+ years
- Substances:Anv600
- Sponsor:Anaveon AG
Rare diseases
Investigational molecules
Locations
Back to France583 clinical trials in Vandoeuvre Les Nancy, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancer types, including head and neck squamous cell carcinoma, multiple myeloma, and prostate cancer. Studies evaluate new therapeutic approaches and diagnostic methods.
Several trials investigate novel drug combinations and targeted therapies for improving patient outcomes.
Comprehensive research into inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. Studies explore innovative treatments including microbiota transplantation and new biological therapies.
Trials aim to develop more effective maintenance therapies and improve quality of life for patients.
Groundbreaking research in multiple sclerosis treatment, including both progressive and relapsing forms. Studies evaluate new therapeutic approaches and disease progression markers.
Focus on developing innovative treatments for better management of neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.